Mean RFS and OS were shorter for patients with MTAP loss (RFS: 23 months, OS: 24 months) compared to those with retained MTAP (RFS: 29 months, OS: 31 months), although these differences did not reach statistical significance ( P = 0.336 for RFS and P = 0.703 for OS; Figure 4 ).
← all excerpts
MTAP protein status is highly concordant with CDKN2A fluorescent in situ hybridization and allows stratification of the luminal subtype in muscle-invasive bladder cancer.
2
0.3360
0.3360
The sentences
Further, MTAP loss showed a trend towards shorter RFS and OS, but did not reach statistical significance, possibly due to the limited sample size and variable follow‐up times.